Founder Reflections on 2023

As I reflect on this past year, 2023 finally brought us some wins in reproductive health. And I personally had the opportunity to contribute to landmark steps forward. ⭐️ The FDA made long awaited changes to the mifepristone REMS program to allow pharmacies to dispense the essential medication. I was part of the research team…

Read More

Misoprostol-Only Medication Abortion Regimen

Political Climate After the U.S. Supreme Court’s decision to eliminate the constitutional protections for abortion in Dobbs v. Jackson Women’s Health Organization in June 2022, access to mifepristone and abortion services in general are being threatened across the country. An ongoing anti-abortion lawsuit in Texas seeks to reverse mifepristone’s FDA approval and remove it from…

Read More

Pharmacists Can Now Dispense Mifepristone Under Updated REMS Program

What Does the January 2023 Update Mean for Mifepristone Dispensing? Mifepristone is a medication that is used to end an early pregnancy. It has been available in the United States since 2000 and is widely used as a safe and effective option for ending a pregnancy during the first 10 weeks. As of January 2023,…

Read More

How Pharmacy Students Can Advocate for Pharmacist Prescribing of Hormonal Contraception

Can pharmacy students advocate for pharmacists prescribing hormonal contraceptives? YES, that is exactly what Wilson Pace, a graduate of the University of Utah College of Pharmacy did. When Wilson heard about the barriers and costs that women experience when accessing contraceptives. His perseverance and dedication to advocacy as a pharmacy student allowed him to take action…

Read More

Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice

Pharmacists in the community setting may soon have the opportunity to ease access to medication abortion in the United States. In the coming months, mifepristone (Mifeprex) is anticipated to have an updated Risk Evaluation and Mitigation Strategy (REMS) Program that allows dispensing through local brick-and-mortar and mail-order pharmacies. This change will integrate pharmacists into abortion…

Read More

Nextstellis®: A new drug update 

  A new combined oral contraceptive was approved by the FDA (Nextstellis®) in April 2021.1 Nextstellis contains estetrol, an estrogen that can be manufactured from plants and that was originally derived naturally during pregnancy from the fetus liver, and drospirenone, a progestin found in other currently available contraceptives. Drospirenone has antiandrogenic and anti-mineralocorticoid activity.2 Estetrol differs…

Read More

A Primer on Reproductive Justice for Pharmacy Professionals

A pharmacy student reflects on what she learned from “Sex & Gender 101” — a gender-inclusive series designed to show learners how to take the first steps to providing care that addresses the specific needs of LGBTQI+ patients. This series includes a glossary of terms, resources for further study, and a “cheat sheet” for providers interacting with patients across the gender spectrum.

Read More

Sex & Gender 101

A pharmacy student reflects on what she learned from “Sex & Gender 101” — a gender-inclusive series designed to show learners how to take the first steps to providing care that addresses the specific needs of LGBTQI+ patients. This series includes a glossary of terms, resources for further study, and a “cheat sheet” for providers interacting with patients across the gender spectrum.

Read More